Kmr 250 Mg/50 Mg/325 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Kmr 250 Mg/50 Mg/325 Mg Tablet safe for pregnant women?
Pregnant women can take Kmr without worrying about any side effects.
Is the use of Kmr 250 Mg/50 Mg/325 Mg Tablet safe during breastfeeding?
Kmr is completely safe for breastfeeding women.
What is the effect of Kmr 250 Mg/50 Mg/325 Mg Tablet on the Kidneys?
Kmr rarely affects the kidneys.
What is the effect of Kmr 250 Mg/50 Mg/325 Mg Tablet on the Liver?
The liver can be affected by Kmr. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart Kmr only after medical advice.
What is the effect of Kmr 250 Mg/50 Mg/325 Mg Tablet on the Heart?
Kmr has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Kmr 250 Mg/50 Mg/325 Mg Tablet unless your doctor advises you to do so -
Is this Kmr 250 Mg/50 Mg/325 Mg Tablet habit forming or addictive?
Kmr 250 Mg/50 Mg/325 Mg Tablet does not cause addiction.
Interaction between Food and Kmr 250 Mg/50 Mg/325 Mg Tablet
There is no information on the effects of taking Kmr 250 Mg/50 Mg/325 Mg Tablet with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Kmr 250 Mg/50 Mg/325 Mg Tablet
Consuming Kmr 250 Mg/50 Mg/325 Mg Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 357
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
KD Tripathi. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 206-207
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Acetaminophen (acetaminophen)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ofirmev (acetaminophen)